The high success rate from one part of the study has come under scrutiny this week. Here’s what we know.
Source
Why Oxford AstraZeneca's Coronavirus Vaccine Data Has Come Under Scrutiny
The high success rate from one part of the study has come under scrutiny this week. Here’s what we know.
Source